Online tool aims to empower myeloma patients

NCT ID NCT05673083

Ongoing Knowledge-focused Sponsor: All4Cure Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests whether a health technology platform called All4Cure can help people with multiple myeloma become more active in managing their own health. Two hundred participants will fill out surveys about their symptoms and how confident they feel in handling their care. No drugs or treatments are being tested—the goal is simply to see if the tool boosts patient engagement.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could show that a simple online tool helps people with multiple myeloma become more involved in their own care, potentially improving their quality of life.
What could go wrong: This is a small pilot study with no drug or treatment being tested. It only measures patient engagement, not disease outcomes, so it may not lead to any direct health improvements.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Patient Participation plasma cell myeloma refractory plasma cell neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MULTIPLE MYELOMA MULTIPLE MYELOMA IN RELAPSE MULTIPLE MYELOMA REFRACTORY MULTIPLE MYELOMA WITH FAILED REMISSION

Contacts and locations

Locations

Cancer Specialists of North Florida

Jacksonville, Florida, 32003, United States
Hematology-Oncology Associates of Central New York

East Syracuse, New York, 13057, United States
Highlands Oncology Group

Fayetteville, Arkansas, 72703, United States
Misson Cancer + Blood

Des Moines, Iowa, 50314, United States
Northwest Medical Specialties PLLC

Tacoma, Washington, 98405, United States
Oklahoma Cancer Specialists and Research Institute

Tulsa, Oklahoma, 74146, United States
Oncology Consultants

Houston, Texas, 77030, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.